Multi-vitamin compound vitamin anti-depression tablet and preparation process thereof
Through nano-encapsulation, emulsification and microencapsulation technology, combined with multi-layer tablet design and functional coating, the problems of antidepressant stability and release control are solved, and the bioavailability and efficacy of the drug are improved.
Patent Information
- Application Number
- CN202411101170.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-19
AI Technical Summary
The stability and bioavailability of existing antidepressants in the production, storage and absorption process lead to many side effects, unsatisfactory efficacy, and it is difficult to achieve precise release control of multiple active ingredients.
Using multi-dimensional complex vitamin antidepressant tablets, Omega-3 fatty acids and probiotics are encapsulated in nanoparticles or microcapsules through nanoparticles, nanoemulsification technology and microencapsulation technology, and a three-layer tablet structure is designed to combine functional Coating technology, controlling the release rate of components.
It improves the absorption rate and stability of active ingredients, avoids component interactions, significantly improves efficacy and patient compliance, extends the shelf life of the product, and achieves time-sharing release of different ingredients.
Smart Images

Figure CN118975998A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a multi-dimensional composite vitamin antidepressant tablet and a preparation process thereof. Background Art
[0002] Depression is a widespread mental disorder worldwide that seriously affects patients' daily life and work ability. Existing antidepressant treatments include medication, psychotherapy, and lifestyle adjustments. In terms of medication, commonly used antidepressants include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and tricyclic antidepressants (TCAs). These drugs relieve depressive symptoms by regulating neurotransmitter levels in the brain.
[0003] However, traditional antidepressants have many limitations and shortcomings. Antidepressants are often accompanied by many side effects, such as nausea, headache, insomnia, weight gain, and sexual dysfunction, which may lead to reduced patient compliance and thus affect the treatment effect. In addition, traditional antidepressants usually take weeks or even months to show significant therapeutic effects, which is a major challenge for patients who are in urgent need of symptom relief. Not all patients respond well to existing antidepressants, and some patients may not respond to multiple drugs, which indicates that the efficacy of existing drugs is limited. Many antidepressants have low bioavailability, that is, the absorption rate and utilization rate of the drug in the body are low, resulting in unsatisfactory efficacy.
[0004] At the same time, existing antidepressant agents have many deficiencies in production, storage, absorption and efficacy. Certain active ingredients such as Omega-3 fatty acids and probiotics are easily degraded during production and storage, resulting in reduced biological activity. The bioavailability of many active ingredients is low, making it difficult to effectively absorb and utilize them in the body. Multiple active ingredients are prone to interact in the same tablet or capsule, affecting their stability and effectiveness. The design of traditional tablets and capsules is difficult to achieve precise release control of multiple active ingredients, resulting in uneven drug release and poor patient compliance. Therefore, in view of the above-mentioned deficiencies, the present invention proposes a multi-dimensional composite vitamin antidepressant tablet and a preparation process thereof. Summary of the invention
[0005] In view of the deficiencies of the prior art, the present invention provides a multi-dimensional composite vitamin antidepressant tablet and a preparation process thereof, which solves the problems of low stability and bioavailability of antidepressant drugs during production, storage and absorption.
[0006] To achieve the above objectives, the present invention is implemented through the following technical scheme: a multi-dimensional composite vitamin antidepressant tablet, comprising the following components by weight percentage: 5%-10% of vitamin B group, 30%-10% of vitamin D, 20%-25% of omega-3 fatty acids, 10%-15% of minerals, 10%-15% of N-acetylcysteine, 1%-3% of melatonin, 5%-8% of L-theanine, 5%-10% of probiotics, 5%-10% of quercetin, and 5%-10% of herbal extracts.
[0007] Preferably, the vitamin B group includes B1, B6, B12 and folic acid.
[0008] Preferably, the minerals include magnesium and zinc.
[0009] Preferably, the herbal extract comprises St. John's wort and saffron.
[0010] The preparation process of the multi-dimensional compound vitamin antidepressant tablet is prepared using the multi-dimensional compound vitamin antidepressant tablet described above, comprising the following steps:
[0011] S1. Material preparation: weigh each component according to weight percentage;
[0012] S2, Nano-encapsulation technology: Omega-3 fatty acids and probiotics are dissolved or dispersed in a solvent, an emulsifier is added, emulsified by a high-pressure homogenizer, and then nano-spray dried to obtain nanoparticles;
[0013] S3, Nanoemulsification technology: Omega-3 fatty acids are mixed with surfactant lecithin, made into nanoemulsion by high-pressure homogenizer, and spray-dried to obtain nanoparticles;
[0014] S4. Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts are encapsulated in biodegradable polymers using spray drying or co-precipitation technology;
[0015] S5, multi-layer tablet technology: the tablet is designed as three layers;
[0016] S6, mixing and granulation: the ingredients of each layer are mixed evenly, and a binder of 5-10% by weight, which is selected from microcrystalline cellulose or starch slurry, is used for wet granulation, and the granules are dried to have a moisture content of less than 5%, and are sieved to size the granules;
[0017] S7, tableting: Use a multi-layer tablet press to press the granules of each layer into tablets layer by layer, and control the weight and thickness of each layer;
[0018] S8. Functional coating: Functional coating of tablets using film coating or multilayer coating technology;
[0019] S9. Quality Control: Perform quality control tests on finished tablets, including appearance, weight, hardness, disintegration time, content uniformity and release characteristics;
[0020] S10. Packaging and storage: Pack the qualified tablets into aluminum foil bags or plastic bottles according to the predetermined quantity, seal them, and store them in a cool and dry place.
[0021] Preferably, the specific operation steps of the nano-encapsulation technology in step S2 are as follows:
[0022] S2.1, Dissolution and dispersion:
[0023] Solvent selection: water, ethanol or a water / ethanol mixed solvent is selected as the solvent, and the ratio of water / ethanol mixed solvent is 1:1;
[0024] Dissolving or dispersing: dissolving or dispersing the omega-3 fatty acids and the probiotics in a solvent respectively;
[0025] S2.2, Emulsification:
[0026] Adding emulsifier: adding 1-3% by weight of emulsifier to the omega-3 fatty acid and probiotic solution;
[0027] Pre-emulsification: Use a magnetic stirrer to pre-emulsify the solution at a stirring speed of 300-500 rpm for 10-15 min;
[0028] S2.3, high pressure homogenization: use a high pressure homogenizer, set the homogenization pressure to 100-150 MPa, perform 3-5 cycles, and maintain the temperature at 25-30°C;
[0029] S2.4. Nano spray drying: Use a nano spray dryer, set the feed rate to 3-5 mL / min, the inlet temperature to 120-140°C, the outlet temperature to 60-80°C, and the spray pressure to 5-8 bar. After drying, collect the nanoparticles through a cyclone separator and store them in a dry environment.
[0030] Preferably, the emulsifier in step S2.2 is lecithin or Tween 80.
[0031] Preferably, the nanoemulsification technology in step S3 specifically includes the following steps:
[0032] S3.1, mixing: mixing omega-3 fatty acids and 1-3% by weight of a surfactant lecithin in a solvent;
[0033] S3.2, high pressure homogenization: the mixture is treated by a high pressure homogenizer, the homogenization pressure is 100-150MPa, the number of cycles is 3-5 times, and the temperature is maintained at 25-30°C;
[0034] S3.3, spray drying: spray drying the nanoemulsion at a feed rate of 3-5 mL / min, an inlet temperature of 120-140° C., an outlet temperature of 60-80° C., and a spray pressure of 5-8 bar to obtain nanoparticles.
[0035] Preferably, the microencapsulation technology in step S4 specifically comprises the following steps:
[0036] S4.1, dissolving and mixing: dissolving or dispersing the omega-3 fatty acids, probiotics and herbal extracts in a solvent;
[0037] S4.2, adding polymer: adding 1-5% by weight of a biodegradable polymer, which can be any one of gelatin, gum arabic or chitosan, and stirring evenly;
[0038] S4.3, emulsification: use a magnetic stirrer for pre-emulsification at a stirring speed of 300-500 rpm for 10-15 minutes;
[0039] S4.4, Spray drying or co-precipitation: Microcapsules are formed by spray drying or co-precipitation technology.
[0040] Preferably, the three layers in step S5 are:
[0041] The first layer: a rapid release layer containing vitamin B complex and vitamin D3;
[0042] The second layer: sustained-release layer, containing N-acetylcysteine, L-theanine and melatonin;
[0043] The third layer: nano-encapsulated layer, containing nano-encapsulated Omega-3 fatty acids and probiotics.
[0044] The present invention provides a multi-dimensional composite vitamin antidepressant tablet and a preparation process thereof. It has the following beneficial effects:
[0045] 1. The present invention encapsulates Omega-3 fatty acids and probiotics in nanoparticles through nano-encapsulation technology and nano-emulsification technology, thereby improving their absorption rate and stability in the body. The nano-encapsulation technology not only protects these active ingredients from degradation during production and storage, but also significantly improves their bioavailability, allowing these ingredients to function more effectively.
[0046] 2. The present invention effectively controls the release rate of each component through a three-layer design, avoiding the interaction between the components, thereby improving the efficacy of the drug and the compliance of the patient. At the same time, the functional coating technology is used to solve the problem that traditional tablets are difficult to achieve time-sharing release of different components, thereby improving the therapeutic effect of the drug.
[0047] 3. The microencapsulation technology of the present invention provides additional protection by encapsulating Omega-3 fatty acids, probiotics and herbal extracts in biodegradable polymers to prevent their degradation during production and storage, thereby extending the shelf life of the product. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 The present invention is a flow chart of the preparation process. DETAILED DESCRIPTION
[0049] The technical solution of the present invention will be described clearly and completely below in conjunction with the accompanying drawings of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0050] Please see attached Figure 1 The embodiment of the present invention provides a multi-dimensional composite vitamin antidepressant tablet, which includes the following components by weight percentage: 5%-10% of vitamin B group, 30%-10% of vitamin D, 20%-25% of omega-3 fatty acids, 10%-15% of minerals, 10%-15% of N-acetylcysteine, 1%-3% of melatonin, 5%-8% of L-theanine, 5%-10% of probiotics, 5%-10% of quercetin, and 5%-10% of herbal extracts.
[0051] Vitamin B complex includes B1, B6, B12 and folic acid.
[0052] Minerals include magnesium and zinc.
[0053] Herbal extracts include St. John's wort and saffron.
[0054] The preparation process of multi-dimensional compound vitamin antidepressant tablets is prepared using the above multi-dimensional compound vitamin antidepressant tablets, comprising the following steps:
[0055] S1. Material preparation: weigh each component according to weight percentage;
[0056] S2, Nano-encapsulation technology: Omega-3 fatty acids and probiotics are dissolved or dispersed in a solvent, an emulsifier is added, emulsified by a high-pressure homogenizer, and then nano-spray dried to obtain nanoparticles;
[0057] S3, Nanoemulsification technology: Omega-3 fatty acids are mixed with surfactant lecithin, made into nanoemulsion by high-pressure homogenizer, and spray-dried to obtain nanoparticles;
[0058] S4. Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts are encapsulated in biodegradable polymers using spray drying or co-precipitation technology;
[0059] S5, multi-layer tablet technology: the tablet is designed as three layers;
[0060] S6, mixing and granulation: the ingredients of each layer are mixed evenly, and a binder of 5-10% by weight, which is selected from microcrystalline cellulose or starch slurry, is used for wet granulation, and the granules are dried to have a moisture content of less than 5%, and are sieved to size the granules;
[0061] S7, tableting: Use a multi-layer tablet press to press the granules of each layer into tablets layer by layer, and control the weight and thickness of each layer;
[0062] S8. Functional coating: Functional coating of tablets using film coating or multilayer coating technology;
[0063] S9. Quality Control: Perform quality control tests on finished tablets, including appearance, weight, hardness, disintegration time, content uniformity and release characteristics;
[0064] S10. Packaging and storage: Pack the qualified tablets into aluminum foil bags or plastic bottles according to the predetermined quantity, seal them, and store them in a cool and dry place.
[0065] The specific operation steps of S2 step nano-encapsulation technology are as follows:
[0066] S2.1, Dissolution and dispersion:
[0067] Solvent selection: water, ethanol or a water / ethanol mixed solvent is selected as the solvent, and the ratio of water / ethanol mixed solvent is 1:1;
[0068] Dissolving or dispersing: dissolving or dispersing the omega-3 fatty acids and the probiotics in a solvent respectively;
[0069] S2.2, Emulsification:
[0070] Adding emulsifier: adding 1-3% by weight of emulsifier to the omega-3 fatty acid and probiotic solution;
[0071] Pre-emulsification: Use a magnetic stirrer to pre-emulsify the solution at a stirring speed of 300-500 rpm for 10-15 min;
[0072] S2.3, high pressure homogenization: use a high pressure homogenizer, set the homogenization pressure to 100-150 MPa, perform 3-5 cycles, and maintain the temperature at 25-30°C;
[0073] S2.4. Nano spray drying: Use a nano spray dryer, set the feed rate to 3-5 mL / min, the inlet temperature to 120-140°C, the outlet temperature to 60-80°C, and the spray pressure to 5-8 bar. After drying, collect the nanoparticles through a cyclone separator and store them in a dry environment.
[0074] In step S2.2, the emulsifier can be any one of lecithin and Tween 80.
[0075] The S3 step nanoemulsification technology specifically includes the following steps:
[0076] S3.1, mixing: mixing omega-3 fatty acids and 1-3% by weight of a surfactant lecithin in a solvent;
[0077] S3.2, high pressure homogenization: the mixture is treated by a high pressure homogenizer, the homogenization pressure is 100-150MPa, the number of cycles is 3-5 times, and the temperature is maintained at 25-30°C;
[0078] S3.3, spray drying: spray drying the nanoemulsion at a feed rate of 3-5 mL / min, an inlet temperature of 120-140° C., an outlet temperature of 60-80° C., and a spray pressure of 5-8 bar to obtain nanoparticles.
[0079] The S4 step microencapsulation technology specifically includes the following steps:
[0080] S4.1, dissolving and mixing: dissolving or dispersing the omega-3 fatty acids, probiotics and herbal extracts in a solvent;
[0081] S4.2, adding polymer: adding 1-5% by weight of a biodegradable polymer, which can be any one of gelatin, gum arabic or chitosan, and stirring evenly;
[0082] S4.3, emulsification: use a magnetic stirrer for pre-emulsification at a stirring speed of 300-500 rpm for 10-15 minutes;
[0083] S4.4, Spray drying or co-precipitation: Microcapsules are formed by spray drying or co-precipitation technology.
[0084] The three layers in step S5 are:
[0085] The first layer: a rapid release layer containing vitamin B complex and vitamin D3;
[0086] The second layer: sustained-release layer, containing N-acetylcysteine, L-theanine and melatonin;
[0087] The third layer: nano-encapsulated layer, containing nano-encapsulated Omega-3 fatty acids and probiotics.
[0088] Embodiment 1:
[0089] formula:
[0090] Vitamin B complex: 7%
[0091] Vitamin D3: 8%
[0092] Omega-3 fatty acids: 22%
[0093] Minerals: 12%
[0094] N-Acetyl Cysteine: 13%
[0095] Melatonin: 2%
[0096] L-Theanine: 6%
[0097] Probiotics: 7%
[0098] Quercetin: 7%
[0099] Herbal extracts: 8%
[0100] Preparation process:
[0101] Material preparation: Weigh each component.
[0102] Nano-encapsulation technology: Omega-3 fatty acids and probiotics were dissolved or dispersed with ethanol, emulsifier Tween 802%, stirring speed 400rpm, time 12 minutes, high-pressure homogenization pressure 120MPa, 4 cycles, nano-spray drying feed rate 4mL / min, inlet temperature 130℃, outlet temperature 70℃, spray pressure 6bar.
[0103] Nanoemulsification technology: Omega-3 fatty acids were mixed with 2% lecithin, homogenization pressure was 120 MPa, cycled 4 times, spray drying feed rate was 4 mL / min, inlet temperature was 130°C, outlet temperature was 70°C, and spray pressure was 6 bar.
[0104] Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts were dissolved in a water / ethanol mixed solvent, 3% gelatin was added, the stirring speed was 400 rpm, the time was 12 minutes, and the microcapsules were formed by spray drying.
[0105] Multi-layer tablet technology: The three layers are a quick-release layer (vitamin B complex and vitamin D3), a sustained-release layer (N-acetylcysteine, L-theanine and melatonin), and a nano-encapsulated layer (nano-encapsulated Omega-3 fatty acids and probiotics).
[0106] Mixing and granulation: The ingredients of each layer were mixed separately, the binder microcrystalline cellulose was 6%, wet granulation was performed, the moisture content of the granules after drying was 4.5%, and the granules were sieved.
[0107] Tablet pressing: Multi-layer tablet press presses the tablets layer by layer.
[0108] Functional coating: film coating.
[0109] Quality Control: Testing appearance, weight, hardness, disintegration time, content uniformity and release characteristics.
[0110] Packaging and storage: sealed in aluminum foil bag.
[0111] Summarize:
[0112] Example 1 provides a basic formula and preparation process of a multi-dimensional multivitamin antidepressant tablet, which enhances the stability and absorption efficiency of the active ingredients through nano-encapsulation and emulsification technology.
[0113] Embodiment 2:
[0114] formula:
[0115] Vitamin B complex: 6.5%
[0116] Vitamin D3: 9%
[0117] Omega-3 fatty acids: 23%
[0118] Minerals: 13%
[0119] N-Acetyl Cysteine: 12%
[0120] Melatonin: 2.5%
[0121] L-Theanine: 6.5%
[0122] Probiotics: 8%
[0123] Quercetin: 6.5%
[0124] Herbal extracts: 8%
[0125] Preparation process:
[0126] Material preparation: Weigh each component.
[0127] Nano-encapsulation technology: Omega-3 fatty acids and probiotics were dissolved or dispersed in a water / ethanol mixed solvent (1:1), emulsifier lecithin 2.5%, stirring speed 450 rpm, time 13 minutes, high-pressure homogenization pressure 130 MPa, 4 cycles, nano-spray drying feed rate 4.5 mL / min, inlet temperature 135 ° C, outlet temperature 75 ° C, spray pressure 6.5 bar.
[0128] Nanoemulsification technology: Omega-3 fatty acids were mixed with 2.5% lecithin, homogenization pressure was 130 MPa, the cycle was repeated 4 times, the spray drying feed rate was 4.5 mL / min, the inlet temperature was 135°C, the outlet temperature was 75°C, and the spray pressure was 6.5 bar.
[0129] Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts were dissolved in a water / ethanol mixed solvent, 4% gum arabic was added, the stirring speed was 450 rpm, the time was 13 minutes, and the microcapsules were formed by spray drying.
[0130] Multi-layer tablet technology: The three layers are a quick-release layer (vitamin B complex and vitamin D3), a sustained-release layer (N-acetylcysteine, L-theanine and melatonin), and a nano-encapsulated layer (nano-encapsulated Omega-3 fatty acids and probiotics).
[0131] Mixing and granulation: The ingredients of each layer were mixed separately, the binder microcrystalline cellulose was 6.5%, wet granulation was performed, the moisture content of the granules after drying was 4.3%, and the granules were sieved.
[0132] Tablet pressing: Multi-layer tablet press presses the tablets layer by layer.
[0133] Functional coating: film coating.
[0134] Quality Control: Testing appearance, weight, hardness, disintegration time, content uniformity and release characteristics.
[0135] Packaging and storage: sealed in aluminum foil bag.
[0136] Summarize:
[0137] Example 2 Based on Example 1, the emulsification and microencapsulation technology is further optimized, the ratio of emulsifier and polymer is increased, and the encapsulation efficiency and stability of the components are improved.
[0138] Embodiment three:
[0139] formula:
[0140] Vitamin B complex: 6%
[0141] Vitamin D3: 9.5%
[0142] Omega-3 fatty acids: 24%
[0143] Minerals: 13.5%
[0144] N-acetylcysteine: 11.5%
[0145] Melatonin: 2.7%
[0146] L-Theanine: 7%
[0147] Probiotics: 8.5%
[0148] Quercetin: 6.3%
[0149] Herbal extracts: 8.5%
[0150] Preparation process:
[0151] Material preparation: Weigh each component.
[0152] Nano-encapsulation technology: Omega-3 fatty acids and probiotics were dissolved or dispersed in a water / ethanol mixed solvent (1:1), emulsifier Tween 80 3%, stirring speed 500 rpm, time 14 minutes, high-pressure homogenization pressure 140 MPa, 4 cycles, nano-spray drying feed rate 5 mL / min, inlet temperature 140 ° C, outlet temperature 78 ° C, spray pressure 7 bar.
[0153] Nanoemulsification technology: Omega-3 fatty acids were mixed with 3% lecithin, homogenization pressure was 140 MPa, cycled 4 times, spray drying feed rate was 5 mL / min, inlet temperature was 140°C, outlet temperature was 78°C, and spray pressure was 7 bar.
[0154] Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts were dissolved in a water / ethanol mixed solvent, 5% chitosan was added, the stirring speed was 500 rpm, the time was 14 minutes, and the microcapsules were formed by spray drying.
[0155] Multi-layer tablet technology: The three layers are a quick-release layer (vitamin B complex and vitamin D3), a sustained-release layer (N-acetylcysteine, L-theanine and melatonin), and a nano-encapsulated layer (nano-encapsulated Omega-3 fatty acids and probiotics).
[0156] Mixing and granulation: The ingredients of each layer are mixed separately, the adhesive starch slurry is 7%, wet granulation is carried out, the moisture content of the granules after drying is 4%, and the granules are sieved.
[0157] Tablet pressing: Multi-layer tablet press presses the tablets layer by layer.
[0158] Functional coating: multi-layer coating technology.
[0159] Quality Control: Testing appearance, weight, hardness, disintegration time, content uniformity and release characteristics.
[0160] Packaging and storage: sealed in aluminum foil bag.
[0161] Summarize:
[0162] Example 3 Based on the previous two examples, the ratio of emulsifier to polymer is further increased, and multi-layer coating technology is adopted to increase the stability and controlled release effect of the tablet.
[0163] Embodiment 4:
[0164] formula:
[0165] Vitamin B complex: 6.2%
[0166] Vitamin D3: 9.8%
[0167] Omega-3 fatty acids: 24.5%
[0168] Minerals: 14%
[0169] N-Acetyl Cysteine: 11%
[0170] Melatonin: 2.8%
[0171] L-Theanine: 7.5%
[0172] Probiotics: 9%
[0173] Quercetin: 6%
[0174] Herbal extracts: 8.7%
[0175] Preparation process:
[0176] Material preparation: Weigh each component.
[0177] Nano-encapsulation technology: Omega-3 fatty acids and probiotics were dissolved or dispersed in a water / ethanol mixed solvent (1:1), emulsifier lecithin 3%, stirring speed 500 rpm, time 14 minutes, high-pressure homogenization pressure 140 MPa, 5 cycles, nano-spray drying feed rate 5 mL / min, inlet temperature 140 ° C, outlet temperature 80 ° C, spray pressure 7.5 bar.
[0178] Nanoemulsification technology: Omega-3 fatty acids were mixed with 3% lecithin, homogenization pressure was 140 MPa, the cycle was repeated 5 times, the spray drying feed rate was 5 mL / min, the inlet temperature was 140°C, the outlet temperature was 80°C, and the spray pressure was 7.5 bar.
[0179] Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts were dissolved in a water / ethanol mixed solvent, 5% chitosan was added, the stirring speed was 500 rpm, the time was 15 minutes, and the microcapsules were formed by spray drying.
[0180] Multi-layer tablet technology: The three layers are a quick-release layer (vitamin B complex and vitamin D3), a sustained-release layer (N-acetylcysteine, L-theanine and melatonin), and a nano-encapsulated layer (nano-encapsulated Omega-3 fatty acids and probiotics).
[0181] Mixing and granulation: The ingredients of each layer are mixed separately, the adhesive starch slurry is 8%, wet granulation is carried out, the moisture content of the granules after drying is 3.8%, and the granules are sieved.
[0182] Tablet pressing: Multi-layer tablet press presses the tablets layer by layer.
[0183] Functional coating: multi-layer coating technology.
[0184] Quality Control: Testing appearance, weight, hardness, disintegration time, content uniformity and release characteristics.
[0185] Packaging and storage: sealed in aluminum foil bag.
[0186] Summarize:
[0187] Example 4 Based on Example 3, the operating parameters of the nano-encapsulation and emulsification technology are further optimized to improve the stability of the ingredients and the controlled release effect of the tablets.
[0188] Embodiment five:
[0189] formula:
[0190] Vitamin B complex: 6.4%
[0191] Vitamin D3: 9.9%
[0192] Omega-3 fatty acids: 24.8%
[0193] Minerals: 14.2%
[0194] N-acetylcysteine: 10.8%
[0195] Melatonin: 2.9%
[0196] L-Theanine: 7.7%
[0197] Probiotics: 9.2%
[0198] Quercetin: 5.8%
[0199] Herbal extracts: 8.9%
[0200] Preparation process:
[0201] Material preparation: Weigh each component.
[0202] Nano-encapsulation technology: Omega-3 fatty acids and probiotics were dissolved or dispersed in a water / ethanol mixed solvent (1:1), emulsifier Tween 80 3%, stirring speed 500 rpm, time 15 minutes, high-pressure homogenization pressure 150 MPa, 5 cycles, nano-spray drying feed rate 5 mL / min, inlet temperature 140 ° C, outlet temperature 80 ° C, spray pressure 8 bar.
[0203] Nanoemulsification technology: Omega-3 fatty acids were mixed with 3% lecithin, homogenization pressure was 150 MPa, the cycle was repeated 5 times, the spray drying feed rate was 5 mL / min, the inlet temperature was 140°C, the outlet temperature was 80°C, and the spray pressure was 8 bar.
[0204] Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts were dissolved in a water / ethanol mixed solvent, 5% chitosan was added, the stirring speed was 500 rpm, the time was 15 minutes, and the microcapsules were formed by spray drying.
[0205] Multi-layer tablet technology: The three layers are a quick-release layer (vitamin B complex and vitamin D3), a sustained-release layer (N-acetylcysteine, L-theanine and melatonin), and a nano-encapsulated layer (nano-encapsulated Omega-3 fatty acids and probiotics).
[0206] Mixing and granulation: The ingredients of each layer are mixed separately, the adhesive starch slurry is 8.5%, wet granulation is carried out, the moisture content of the granules after drying is 3.5%, and the granules are sieved.
[0207] Tablet pressing: Multi-layer tablet press presses the tablets layer by layer.
[0208] Functional coating: multi-layer coating technology.
[0209] Quality Control: Testing appearance, weight, hardness, disintegration time, content uniformity and release characteristics.
[0210] Packaging and storage: sealed in aluminum foil bag.
[0211] Summarize:
[0212] Example 5 Based on Example 4, the parameters of high-pressure homogenization and spray drying are further optimized to improve the uniformity and stability of the nanoparticles and enhance the controlled release effect of the tablets.
[0213] Summary:
[0214] The above five embodiments all meet the technical solution of multi-dimensional compound vitamin antidepressant tablets, gradually deepen from the basic formula and preparation process, and continuously improve the stability, absorption efficiency and controlled release effect of the ingredients by optimizing emulsifiers, polymers and operating parameters. Each embodiment is further creatively optimized on the basis of the previous one, ensuring the high quality and efficacy of the tablets.
[0215] Research test 1: ingredient stability test
[0216] Purpose:
[0217] Verify the effect of nano-encapsulation and nano-emulsification technology on improving the stability of Omega-3 fatty acids, probiotics and herbal extracts, and ensure long-term storage stability under different temperature and humidity conditions.
[0218] Experimental steps:
[0219] Sample preparation:
[0220] Three groups of samples were prepared: tablets treated with nanoencapsulation and nanoemulsification (test group 1), tablets treated with nanoencapsulation only (test group 2), and tablets not treated with nanotechnology (control group), with 100 tablets in each group.
[0221] Conditional simulation:
[0222] The samples were stored in a constant temperature and humidity chamber and the following conditions were set:
[0223] 25℃ / 60%RH
[0224] 37℃ / 75%RH
[0225] Storage period: 0, 1, 3, 6, 12 months.
[0226] Detection indicators:
[0227] Ten samples were taken for testing at each time point.
[0228] The contents of omega-3 fatty acids, probiotics and herbal extracts were determined using high performance liquid chromatography (HPLC) and gas chromatography (GC).
[0229] Table 1:
[0230]
[0231]
[0232] Summary of results:
[0233] The experimental results show that nano-encapsulation and nano-emulsification technology significantly improves the stability of Omega-3 fatty acids, probiotics and herbal extracts. Test group 1 maintained a high content of ingredients at each time point, and compared with the control group and test group 2, test group 1 showed better stability after long-term storage. This shows that nanotechnology has significant advantages in ingredient stability and can effectively extend the shelf life of the product.
[0234] Research experiment 2: Absorption efficiency test
[0235] Purpose:
[0236] Verify the effect of nano-encapsulation and nano-emulsification technology on improving the absorption efficiency of Omega-3 fatty acids, probiotics and herbal extracts in experimental animals, and ensure the efficient utilization of the ingredients in the body.
[0237] Experimental steps:
[0238] Subjects:
[0239] Thirty healthy rats were selected and randomly divided into three groups, with 10 rats in each group.
[0240] Test group 1 took tablets treated with nanoencapsulation and nanoemulsification, test group 2 took tablets treated with nanoencapsulation only, and the control group took tablets not treated with nanotechnology.
[0241] Dosage:
[0242] Each rat was given an equal amount of tablets per day according to the rat's body weight for 7 consecutive days.
[0243] Detection indicators:
[0244] On the 7th day, blood samples were collected through the tail vein at 0 h, 1 h, 2 h, 4 h, 8 h, and 24 h after administration.
[0245] High performance liquid chromatography (HPLC) was used to measure the plasma concentrations of omega-3 fatty acids, probiotics, and herbal extracts.
[0246] Table 2:
[0247]
[0248]
[0249] Summary of results:
[0250] The experimental results showed that the plasma concentrations of test group 1 and test group 2 at each time point were significantly higher than those of the control group, especially test group 1, which had the best absorption efficiency. This shows that nanoencapsulation and nanoemulsification technology can significantly improve the absorption efficiency of ingredients in the body and ensure that the effective ingredients can be more efficiently utilized by the body. It is speculated that the application of this technology to humans may also have similar effects, and further research is expected to verify its superiority in human clinical trials.
[0251] Research Trial 3: Antidepressant Effect Trial
[0252] Purpose:
[0253] To evaluate the clinical efficacy of multivitamin antidepressant tablets in patients with depression and to determine their superiority by comparing them with existing antidepressant tablets on the market.
[0254] Experimental steps:
[0255] Subjects:
[0256] Sixty patients with mild to moderate depression were recruited and randomly divided into three groups, with 20 people in each group.
[0257] Test group 1 took the tablets of the present invention (nano-encapsulated and nano-emulsified), test group 2 took the tablets only treated with nano-encapsulation, and the control group took the existing antidepressant tablets on the market.
[0258] Test cycle:
[0259] The patients were taken for 8 consecutive weeks with follow-up visits once a week.
[0260] Detection indicators:
[0261] Depression symptoms were assessed using the Hamilton Depression Rating Scale (HAMD) and the Beck Depression Inventory (BDI).
[0262] Adverse reactions were recorded.
[0263] Table 3:
[0264]
[0265]
[0266] Summary of results:
[0267] The experimental results showed that the depressive symptom improvement effects of test group 1 and test group 2 were significantly better than those of the control group, especially test group 1, which had the largest decrease in HAMD and BDI scores and the lowest adverse reaction rate. This shows that the multi-dimensional multivitamin antidepressant tablets of the present invention have obvious advantages in antidepressant effects and are relatively safe.
[0268] Research trial 4: Tablet controlled release effect test
[0269] Purpose:
[0270] Verify the control effect of the fast-release layer, sustained-release layer and nano-encapsulation layer on the ingredient release rate achieved by the multi-layer tablet technology to ensure the optimal release time of each ingredient.
[0271] Experimental steps:
[0272] Sample preparation:
[0273] Multilayer tablet samples (including a quick-release layer, a sustained-release layer and a nano-encapsulation layer) and common tablet samples (single layer) were prepared, with 30 tablets in each group.
[0274] In vitro dissolution test:
[0275] Dissolution tests were carried out under simulated gastrointestinal environment (pH 1.2 and pH 6.8).
[0276] Samples were taken at each time point (0, 0.5, 1, 2, 4, 6, and 8 hours) to determine the dissolution amounts of vitamin B complex, vitamin D3, N-acetylcysteine, L-theanine, Omega-3 fatty acids, and probiotics.
[0277] Detection method:
[0278] The contents of ingredients were determined using HPLC and UV-Vis spectrophotometry.
[0279] Table 4:
[0280]
[0281]
[0282] Summary of results:
[0283] The experimental results show that the release rate of the ingredients in the multilayer tablets at each time point is better than that of ordinary tablets, and the release time of the ingredients in each layer is effectively controlled. The rapid release layer, sustained release layer and nano-encapsulation layer of the multilayer tablets release ingredients at different time points, ensuring the best absorption time and effect. This shows that the multilayer tablet technology has significant advantages in controlled release.
[0284] Research experiment 5: Comprehensive effect experiment
[0285] Purpose:
[0286] The overall effect and user satisfaction of the tablets of the present invention in actual use were comprehensively evaluated, and compared with similar products currently available on the market to determine their overall superiority.
[0287] Experimental steps:
[0288] Subjects:
[0289] 60 target user groups (such as adults in sub-health conditions, white-collar workers with high work pressure, etc.) were recruited and randomly divided into three groups, with 20 people in each group.
[0290] The test group 1 took the tablets of the present invention (nano-encapsulated and nano-emulsified), the test group 2 took the tablets only treated with nano-encapsulation, and the control group took the existing similar products on the market.
[0291] Test cycle:
[0292] The treatment lasted for 12 weeks, with follow-up every 4 weeks.
[0293] Detection indicators:
[0294] The users’ physical condition, mental state, sleep quality, anti-fatigue effect and satisfaction were evaluated through questionnaires, and any adverse reactions were recorded.
[0295] Table 5:
[0296]
[0297]
[0298] Summary of results:
[0299] The experimental results show that the physical condition, mental state, sleep quality and anti-fatigue effect of test group 1 and test group 2 are significantly better than those of the control group, especially test group 1, which has the highest user satisfaction and the lowest adverse reaction rate. This shows that the multi-dimensional multivitamin antidepressant tablets of the present invention have obvious advantages in comprehensive effects and can effectively improve the overall health status and quality of life of users.
[0300] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A multi-dimensional multivitamin antidepressant tablet, characterized in that: Calculated by weight percentage, the invention comprises the following components: 5%-10% of B vitamins, 30%-10% of vitamin D, 20%-25% of omega-3 fatty acids, 10%-15% of minerals, 10%-15% of N-acetylcysteine, 1%-3% of melatonin, 5%-8% of L-theanine, 5%-10% of probiotics, 5%-10% of quercetin, and 5%-10% of herbal extracts.
2. The multi-dimensional multivitamin antidepressant tablet according to claim 1, characterized in that: The vitamin B group includes B1, B6, B12 and folic acid.
3. The multi-dimensional multivitamin antidepressant tablet according to claim 1, characterized in that: Such minerals include magnesium and zinc.
4. The multi-dimensional multivitamin antidepressant tablet according to claim 1, characterized in that: The herbal extracts include St. John's wort and saffron.
5. A process for preparing a multi-dimensional multivitamin antidepressant tablet, characterized in that: The preparation method of the multi-dimensional multivitamin antidepressant tablets according to any one of claims 1 to 4 comprises the following steps: S1. Material preparation: weigh each component according to weight percentage; S2, Nano-encapsulation technology: Omega-3 fatty acids and probiotics are dissolved or dispersed in a solvent, an emulsifier is added, emulsified by a high-pressure homogenizer, and then nano-spray dried to obtain nanoparticles; S3, Nanoemulsification technology: Omega-3 fatty acids are mixed with surfactant lecithin, made into nanoemulsion by high-pressure homogenizer, and spray-dried to obtain nanoparticles; S4. Microencapsulation technology: Omega-3 fatty acids, probiotics and herbal extracts are encapsulated in biodegradable polymers using spray drying or co-precipitation technology; S5, multi-layer tablet technology: the tablet is designed as three layers; S6, mixing and granulation: the ingredients of each layer are mixed evenly, and a binder of 5-10% by weight, which is selected from microcrystalline cellulose or starch slurry, is used for wet granulation, and the granules are dried to have a moisture content of less than 5%, and are sieved to size the granules; S7, tableting: Use a multi-layer tablet press to press the granules of each layer into tablets layer by layer, and control the weight and thickness of each layer; S8. Functional coating: Functional coating of tablets using film coating or multilayer coating technology; S9. Quality Control: Perform quality control tests on finished tablets, including appearance, weight, hardness, disintegration time, content uniformity and release characteristics; S10. Packaging and storage: Pack the qualified tablets into aluminum foil bags or plastic bottles according to the predetermined quantity, seal them, and store them in a cool and dry place.
6. The process for preparing the multi-dimensional composite vitamin antidepressant tablet according to claim 5, characterized in that: The specific operation steps of the nano-encapsulation technology in step S2 are as follows: S2.1, Dissolution and dispersion: Solvent selection: water, ethanol or a water / ethanol mixed solvent is selected as the solvent, and the ratio of water / ethanol mixed solvent is 1:1; Dissolving or dispersing: dissolving or dispersing the omega-3 fatty acids and the probiotics in a solvent respectively; S2.2, Emulsification: Adding emulsifier: adding 1-3% by weight of emulsifier to the omega-3 fatty acid and probiotic solution; Pre-emulsification: Use a magnetic stirrer to pre-emulsify the solution at a stirring speed of 300-500 rpm for 10-15 min; S2.3, high pressure homogenization: use a high pressure homogenizer, set the homogenization pressure to 100-150 MPa, perform 3-5 cycles, and maintain the temperature at 25-30°C; S2.
4. Nano spray drying: Use a nano spray dryer, set the feed rate to 3-5 mL / min, the inlet temperature to 120-140°C, the outlet temperature to 60-80°C, and the spray pressure to 5-8 bar. After drying, collect the nanoparticles through a cyclone separator and store them in a dry environment.
7. The process for preparing the multi-dimensional composite vitamin antidepressant tablet according to claim 5, characterized in that: The emulsifier in step S2.2 is optionally lecithin or Tween 80.
8. The process for preparing the multi-dimensional composite vitamin antidepressant tablet according to claim 5, characterized in that: The nanoemulsification technology in step S3 specifically includes the following steps: S3.1, mixing: mixing omega-3 fatty acids and 1-3% by weight of a surfactant lecithin in a solvent; S3.2, high pressure homogenization: the mixture is treated by a high pressure homogenizer, the homogenization pressure is 100-150MPa, the number of cycles is 3-5 times, and the temperature is maintained at 25-30°C; S3.3, spray drying: spray drying the nanoemulsion at a feed rate of 3-5 mL / min, an inlet temperature of 120-140° C., an outlet temperature of 60-80° C., and a spray pressure of 5-8 bar to obtain nanoparticles.
9. The process for preparing the multi-dimensional composite vitamin antidepressant tablet according to claim 5, characterized in that: The microencapsulation technology in step S4 specifically includes the following steps: S4.1, dissolving and mixing: dissolving or dispersing the omega-3 fatty acids, probiotics and herbal extracts in a solvent; S4.2, adding polymer: adding 1-5% by weight of a biodegradable polymer, which can be any one of gelatin, gum arabic or chitosan, and stirring evenly; S4.3, emulsification: use a magnetic stirrer for pre-emulsification at a stirring speed of 300-500 rpm for 10-15 minutes; S4.4, Spray drying or co-precipitation: Microcapsules are formed by spray drying or co-precipitation technology.
10. The process for preparing the multi-dimensional composite vitamin antidepressant tablet according to claim 5, characterized in that: The three layers in step S5 are: The first layer: a rapid release layer containing vitamin B complex and vitamin D3; The second layer: sustained-release layer, containing N-acetylcysteine, L-theanine and melatonin; The third layer: nano-encapsulated layer, containing nano-encapsulated Omega-3 fatty acids and probiotics.
